Home / Recalls / Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy / D-1142-2019

D-1142-2019 Class II Terminated

Recalled by Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy — Bristol, TN

Recall Details

Product Type
Drugs
Report Date
April 24, 2019
Initiation Date
April 2, 2019
Termination Date
September 24, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1 syringe

Product Description

DMSO 50% 60 mL/Heparin 1 mL/ Sodium Bicarbonate 60 mL/ Solu-Cortef 100 mg, 41 mL syringe, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.

Reason for Recall

Lack of sterility assurance.

Distribution Pattern

Nationwide

Code Information

All Lots

Other recalls by Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy

  • D-1193-2019 Class II — Gentamicin 240 mg/500 mL Sterile Water for Irrigation,60 mL Syringe, Anderson Co (April 2, 2019)
  • D-1196-2019 Class II — HCG 11,00Units/B 12 11,000 mcg Injection, 30 mL Vial, Anderson Compounding Pharm (April 2, 2019)
  • D-1175-2019 Class II — Sermorelin 0.3 mg/0.5 mL, 10 mL Vial, Anderson Compounding Pharmacy 310 Bluff Ci (April 2, 2019)
  • D-1176-2019 Class II — Sermorelin 0.4 mg/0.5 mL, 10 mL Vial, Anderson Compounding Pharmacy 310 Bluff Ci (April 2, 2019)
  • D-1161-2019 Class II — Methionine 15mg/Choline 100mg/ Inositol 50mg/ Methylcobalamin 1mg/ Lidocoaine 10 (April 2, 2019)
  • D-1162-2019 Class II — Methylcobalamin 1 mg/mL Injection, 2 mL Vial, Anderson Compounding Pharmacy 310 (April 2, 2019)
  • D-1170-2019 Class II — Prostaglandin 60 mcg/mL, Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, (April 2, 2019)
  • D-1164-2019 Class II — Morphine Sulfate 5 mg/3mL Inhalation, 3 mL Vials, Anderson Compounding Pharmacy (April 2, 2019)
  • D-1169-2019 Class II — Prostaglandin 40 mcg/mL, Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, (April 2, 2019)
  • D-1141-2019 Class II — Dexamethasone 24 mg/mL Injection, 10 mL Vial, Anderson Compounding Pharmacy, 31 (April 2, 2019)